Table 3 Association of Gal3ST1 expression (negative vs. positive) with risk factors (Fisher’s exact test).
From: The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma
parameter | level | Gal3ST—(%) | Gal3ST + (%) | p |
|---|---|---|---|---|
n | 23 | 96 | ||
Sex (%) | m | 16 (69.6) | 69 (71.9) | 0.802 |
w | 7 (30.4) | 27 (28.1) | ||
Age (median [IQR]) | 63.00 [52.00—71.50] | 64.00 [55.00–70.00] | 0.699 | |
T Stage (%) | pT1 | 12 (52.2) | 51 (53.1) | 0.217 |
pT2 | 6 (26.1) | 12 (12.5) | ||
pT3/4 | 5 (21.7) | 33 (34.4) | ||
Grading (%) | G1 | 3 (17.6) | 11 (11.7) | 0.300 |
G2 | 11 (64.7) | 75 (79.8) | ||
G3 | 3 (17.6) | 8 (8.5) | ||
N Status (%) | 0 | 22 (95.7) | 92 (95.8) | 1.000 |
1 | 1 (4.3) | 4 (4.2) | ||
M Status (%) | M0 | 20 (87.0) | 87 (90.6) | 0.699 |
M1 | 3 (13.0) | 9 (9.4) | ||
Histology (%) | ccRCC | 13 (56.5) | 81 (84.4) | < 0.001 |
pRCC | 4 (17.4) | 13 (13.5) | ||
chRCC | 6 (26.1) | 2 (2.1) | ||
chRCC (%) | no | 17 (73.9) | 94 (97.9) | 0.001 |
yes | 6 (26.1) | 2 (2.1) | ||
V Status (%) | 0 | 18 (78.3) | 76 (79.2) | 0.817 |
1 | 3 (13.0) | 15 (15.6) | ||
2 | 2 (8.7) | 5 (5.2) | ||
RSF* (%) | 0 | 21 (91.3) | 92 (95.8) | 0.328 |
1 | 2 (8.7) | 4 (4.2) | ||
Sarcomatoid morphology (%) | 0 | 23 (100.0) | 95 (99.0) | 1.000 |
1 | 0 (0.0) | 1 (1.0) | ||
R Status (%) | 0 | 21 (95.5) | 90 (95.7) | 1.000 |
1/2 | 1 (4.5) | 4 (4.3) | ||
L Status (%) | 0 | 23 (100.0) | 92 (95.8) | 1.000 |
1 | 0 (0.0) | 4 (4.2) |
